MB ChB, PhD, FRCP(Glas), FRCPath.
Professor of Haematology & Myeloma Studies, Honorary Consultant Haematologist
Clinical Director (haematology) CTRU
Experimental Haematology, Leeds Institute of Cancer & Pathology, University of Leeds. Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds
I am a graduate of the University of Glasgow School of Medicine & received my higher professional training in haematology in the West of Scotland. After completion of my PhD, I was appointed as a Consultant Haematologist in the West of Scotland before moving to take up the post of Director of Stem Cell Transplantation at Leeds Teaching Hospitals in 2002. In 2013 I was appointed as Professor of Haematology, University of Leeds where I lead the myeloma clinical and translational research portfolio with a primary interest in tumour immunology and immunotherapy.
I am the Chair of the UK Myeloma Research Alliance and NCRI Myeloma sub-group as well as a member of the NCRI Haematology- Oncology Clinical Studies Group. I am the chair of the UK Myeloma Forum and have represented the interests of both myeloma clinicians and patients in NICE reviews. I am Chief Investigator for NCRI Myeloma X (completed), UKMRA Myeloma XII (in recruitment), UKMRA Myeloma XIV (in set-up), MUKeight (in recruitment) and MUKeleven (in recruitment). My collaboration with industry includes my position as the UK Chief investigator for 4 industry international phase III and IIIb studies & I am the chair of the Myeloma UK Research Advisory Group and Medical Editor of Myeloma Today. Finally I hold the posts of Clinical Director of NIHR (Leeds) IVD Cooperative and Clinical Director (Haematology), CTRU, University of Leeds.